Drug · DIN 02354950
DEXILANT
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since January 13, 2017; first marketed August 5, 2010.
- Drug Identification Number (DIN)
- 02354950
- Company (DIN owner)
- Takeda Canada IncorporatedToronto, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Capsule (Delayed-Release)
- Route
- Oral; Nasogastric
- Therapeutic class (ATC)
- Dexlansoprazole A02BC06
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| DEXLANSOPRAZOLE | 30 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- December 16, 2016: NOC 18777Supplement to a New Drug Submission (SNDS) · Update to the lalbelling of the safety information with respect to interaction with antiretroviral products
- July 22, 2010: NOC 11609New Drug Submission (NDS)
Other DINs named DEXILANT
- DIN 02354969 · Marketed